Rubedo Life Sciences

Sharing the latest from @NatureNeuro journal: Our computational work at @LifeRubedo in collaboration with leading scientists from @StanfordMed is featured on the cover. Grateful for the opportunity to contribute to such impactful work in a small capacity. nature.com/articles/s4159…

We’re excited to announce a major milestone at Rubedo Life Sciences: our first patients have been dosed! With this, Rubedo officially enters the clinic as a clinical-stage longevity biotech. businesswire.com/news/home/2025…

breakthrough discovery: featured on the cover, our new paper on Nature Neuroscience with Prof. Tawfik lab at Stanford University, showing first-in-class senescence sensory neurons to treat neuropathic pain businesswire.com/news/home/2025…

We are excited to announced a strategic partnership with @Beiersdorf_AG to advance the skincare industry with a disruptive and innovative product, born from deep science of aging and cellular senescence biology businesswire.com/news/home/2024…

We are stocked to announced that we closed our $40M+ Series A led by @khoslaventures and Ahren Innovation capital to advance the company to the clinic with our first program, entry point to broader therapeutic areas of chronic diseases of aging businesswire.com/news/home/2024…

💣New investment for IAG #businessangels: @LifeRubedo 👩‍🔬 #biopharmaceuticals Rubedo Life Sciences secures a substantial $40M Series A financing round, with a focus on advancing groundbreaking therapies targeting age-related diseases. italianangels.net/en/news/new-in…

.@LifeRubedo just brought in $40 million in a series A financing round co-led by @khoslaventures and Ahren Innovation Capital. The start-up will develop medicines for aging cells that drive skin and fibrotic diseases: cen.acs.org/business/start…

Rubedo lands $40m to advance senescence-targeting therapeutics into clinical trials... Longevity biotech @LifeRubedo plans Phase 1 #senotherapeutics trial this year as it seeks to keep people ‘biologically young.’ #longevity #investment #senescence longevity.technology/news/rubedo-la…

Celebrating with @khoslaventures team and Rubedo team our Series A and the partnering deal with @Beiersdorf_AG

@tweeter celebrating our $40M+ Series A led by @khoslaventures and Ahren Innovation Capital to advance Rubedo to the clinic with our first program, entry point to larger therapeutic areas of chronic diseases of aging businesswire.com/news/home/2024…

@tweeter announcing our partnership with @Beiersdorf_AG to disrupt and innovate together the skincare industry with the first real rejuvenative product, born from @StanfordMed and @Rubedolife deep science of cellular senescence and aging biology businesswire.com/news/home/2024…

We are excited to share the report of the Seno-Therapeutics Summit 2023. You can read the paper now published on Nature Portfolio journal npj #aging by Summit chairs Dr. Marco Quarta, our President, and Dr. Marco Demaria, our Chairman of the SAB. nature.com/articles/s4151…

@PhaedonInstitut is hosting a Senotherapeutics Summit at Buck on Nov 7-8. Fantastic line up of speakers and panelists all focused on #senescence. Register here: phaedon.institute/summit/registe… #phaedoninstitute #senotherapeuticsummit2023 #longevity

"There are no competitors in senotherapeutics – we are all collaborators." Great article by @LongevityTech discussing the upcoming #SenoTherapeuticsSummit with our President @MarcoQuarta12!

The RIse of Longevity Therapeutics - nice article on Pharma Exec by Dr. @Marco4Quarta12 CEO & CoFounder of Rubedo pharmexec.com/view/the-rise-…

great article on @LifeRubedo by @LongevityTech longevity.technology/longevity-seno…

TODAY: @bioagelabs CEO @kpfortney joins a Clubhouse Q&A about the @beOnDeck Longevity Biotech Fellowship. ODLB brings people together to build, join, and invest in revolutionary longevity biotechnology startups! Monday, July 12, 10:30 AM PDT clubhouse.com/event/Mwab7e2B

Be sure to check out the latest @PrimeMoversLab webinar on Wednesday at 12:00 PT/3:00 ET exploring the technologies that are helping us live longer and the startups making the biggest breakthroughs. Register here: bit.ly/3e4XmWy